SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Wells Fargo Reiterates Outperform On CRISPR Therapeutics, Raises Price Target To $95

Wells Fargo reiterates CRISPR Therapeutics (NASDAQ:CRSP) with a Outperform and raises the price target from $65 to $95.

Benzinga · -

Wells Fargo reiterates CRISPR Therapeutics (NASDAQ:CRSP) with a Outperform and raises the price target from $65 to $95.